Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Atherosclerosis. 2009 Dec 5;210(2):555–562. doi: 10.1016/j.atherosclerosis.2009.12.002

Table 5.

Postprandial lipids, lipoproteins, apoproteins and hsCRP at the end of test phases

Low Lys:Arg High Lys:Arg P value
Total cholesterol (mg/dL) 202 ± 24 207 ± 28 0.073
LDL cholesterol (mg/dL)# 128 ± 18 126 ± 20 0.904
VLDL cholesterol (mg/dL)* 22 ± 11 29 ± 16 0.001
HDL cholesterol (mg/dL) 52 ± 12 53 ± 12 0.594
Triglyceride (mg/dL)* 137 ± 52 178 ± 80 0.001
Total cholesterol:HDL
cholesterol#
4.03 ± 0.89 4.09 ± 0.93 0.050
Lipoprotein (a) (mg/dL)# 33.8 ± 25.0 34.3 ± 26.3 0.057
Apoprotein AI (mg/dL) 147.0 ± 21.9 151.4 ± 21.9 0.018
Apoprotein B (mg/dL)# 98.5 ± 13.6 100.3 ± 15.7 0.136
hsCRP (mg/dL) 1.81 ± 2.30 2.34 ± 2.89 0.020

A paired t-test was carried out for each variable.

*

Transformed to log10 values before statistical analysis.

#

Transformed to rank data before statistical analysis.